Kennan Marsh

2.0k citations

17 papers · 1.5k indexed · 1 hit paper · h-index 10

Impact in

Organic Chemistry top 5%
- Synthesis and biological activity
- Multicomponent Synthesis of Heterocycles
- Click Chemistry and Applications
- Synthesis and Biological Evaluation
Molecular Biology top 10%
- Metabolism, Diabetes, and Cancer

Papers in

Pharmacology 3
Molecular Biology 12
- Protein Kinase Regulation and GTPase Signaling 3
- Nicotinic Acetylcholine Receptors Study 3
- Retinoids in leukemia and cellular processes 2
- Histone Deacetylase Inhibitors Research 2
- Receptor Mechanisms and Signaling 2
- Angiogenesis and VEGF in Cancer 2

Co-authors: Barbara L. Cool Robert Dickinson Ernst U. Frevert Paul Jung Ning Cao William J. Chiou Bradley A. Zinker Gang Zhao
Journals: Journal of Medicinal Chemistry (4 papers)Bioorganic & Medicinal Chemistry Letters (3 papers)Journal of Clinical Oncology (2 papers)Cell Metabolism (1 paper)Alzheimer s & Dementia (1 paper)
Partner nations: United States United Kingdom Germany

In The Last Decade

Kennan Marsh

17 papers receiving 1.4k citations

Hit Papers

align trajectories log scale

Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome 2006 · 733 citations

Peers

Countries citing papers authored by Kennan Marsh

Since Specialization

Citations

This map shows the geographic impact of Kennan Marsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kennan Marsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kennan Marsh more than expected).

Fields of papers citing papers by Kennan Marsh

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kennan Marsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kennan Marsh. The network helps show where Kennan Marsh may publish in the future.

Co-authors

The 25 scholars most cited alongside Kennan Marsh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kennan Marsh Line = papers co-authored together Kennan Marsh links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work
1	Discovery of Novel and Highly Selective Inhibitors of Calpain for the Treatment of Alzheimer’s Disease: 2-(3-Phenyl-1H-pyrazol-1-yl)-nicotinamides Journal of Medicinal Chemistry ·Andreas Kling, Katja Jantos, Helmut Mack, Wilfried Hornberger, Karla Drescher, Volker Nimmrich, Rednaj Mota Santos, Karsten Wicke, Charles W. Hutchins, Yanbin Lao, Kennan Marsh, 최박광	2017	33
2	P4–310: Preclinical characterization of a selective alpha‐7 neuronal nicotinic acetylcholine receptor agonist ABT‐126: A novel therapeutic agent for the treatment of cognitive impairment in Alzheimer's disease and schizophrenia Alzheimer s & Dementia ·Robert S. Bitner, David J. Anderson, Karla Drescher, Kathy L. Kohlhaas, Alemania. Ministerio Federal de Cooperación Económica y Desarrollo, Min Hu, Jinhe Li, Stella Markosyan, Kennan Marsh, Eric G. Mohler, Arthur L. Nikkel, Richard J. Radek, Holly M. Robb, Michael R. Schrimpf, Jeffrey F. Waring, 郑慧玉, Murali Gopalakrishnan	2013	9
3	Zotarolimus, a Novel Sirolimus Analogue With Potent Anti-proliferative Activity on Coronary Smooth Muscle Cells and Reduced Potential for Systemic Immunosuppression Journal of Cardiovascular Pharmacology ·Yung‐Wu Chen, Morey L. Smith, Michael P. Sheets, Tomio Inukai, James M. Trevillyan, Sandra E. Burke, Muhamad Riyadi Putra, Agnes Y. Song, Rolf Wagner, Joy Bauch, Kennan Marsh, Thomas A. Fey, Gin C. Hsieh, Donna M. Gauvin, Karl W. Mollison, George W. Carter, Stevan W. Djurić	2007	55
4	Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome Cell Metabolism ·Barbara L. Cool, Bradley A. Zinker, William J. Chiou, Lemma Kifle, Ning Cao, K Mainhard, Robert Dickinson, Andrew Adler, Gerard D. Gagné, Rajesh Iyengar, Gang Zhao, Kennan Marsh, Philip R. Kym, Paul Jung, Heidi S. Camp, Ernst U. Frevert Hit paper breakdown →	2006	733
5	Identification of a novel 3,5-disubstituted pyridine as a potent, selective, and orally active inhibitor of Akt1 kinase Bioorganic & Medicinal Chemistry Letters ·Sheela A. Thomas, Tongmei Li, Keith W. Woods, Xiaohong Song, Garrick K. Packard, John P. Fischer, R. Bruce Diebold, Xuesong Liu, Yan Shi, Vered Klinghofer, Eric F. Johnson, Jennifer J. Bouska, Amanda M. Olson, Ran Guan, Yaşar Özgün Topkara, Kennan Marsh, Yan Luo, Saul H. Rosenberg, Vincent L. Giranda, Qun Li	2006	11
6	The Bcl-2 Family Inhibitor ABT-263 Shows Significant but Reversible Thrombocytopenia in Mice. Blood ·Alex R. Shoemaker, Michael J. Mitten, Jessica Adickes, Anatol Oleksijew, Haichao Zhang, Joy Bauch, Kennan Marsh, David J. Frost, David J. Madar, Christin Tse, Stephen W. Fesik, Saul H. Rosenberg, Steven W. Elmore	2006	5
7	Antitumor Activity of Orally Bioavailable Farnesyltransferase Inhibitor, ABT-100, Is Mediated by Antiproliferative, Proapoptotic, and Antiangiogenic Effects in Xenograft Models Clinical Cancer Research ·Debra C. Ferguson, Luis E. Rodrı́guez, Joann P. Palma, Marion Refici, George Papageorgiou, Jacqueline M. O’Connor, Gerard M. Sullivan, David J. Frost, Kennan Marsh, Joy Bauch, Haiying Zhang, Nan‐Horng Lin, Saul H. Rosenberg, Hing L. Sham, Ingrid B.J. Joseph	2005	20
8	Pharmacokinetics (PK) of the angiogenesis inhibitor ABT-510 in healthy subjects Journal of Clinical Oncology ·Chetan S. Karyekar, Robert A. Carr, H. Kreipe O. Gluz, Rongfei Sheng, Marilía Caridad, Kennan Marsh, А А Калинников, Rod Humerickhouse	2004	8
9	Pharmacokinetics (PK) of the angiogenesis inhibitor ABT-510 in healthy subjects Journal of Clinical Oncology ·Chetan S. Karyekar, Robert A. Carr, H. Kreipe O. Gluz, Rongfei Sheng, Marilía Caridad, Kennan Marsh, А А Калинников, Rod Humerickhouse	2004	1
10	The synthesis and biological evaluation of a novel series of antimicrobials of the oxazolidinone class Bioorganic & Medicinal Chemistry Letters ·Richard J. Sciotti, Marina Pliushchev, Paul E. Wiedeman, Akbar Ade Firmansyah, Robert K. Flamm, Angela M. Nilius, Kennan Marsh, DeAnne Stolarik, Robert A. Jolly, Roger G. Ulrich, Stevan W. Djurić	2002	49
11	Potent, Orally Active Heterocycle-Based Combretastatin A-4 Analogues: Synthesis, Structure−Activity Relationship, Pharmacokinetics, and In Vivo Antitumor Activity Evaluation Journal of Medicinal Chemistry ·Le Wang, Keith W. Woods, Qun Li, Kenneth J. Barr, Benny Maria Lumbantoruan, Steven M. Hannick, Germán Aníbal Martínez Valderrama, R.B. Credo, FRANK W. PICKEL, Kennan Marsh, Robert B. Warner, Jang Y. Lee, B. Ramakers, David J. Frost, Saul H. Rosenberg, Hing L. Sham	2002	381
12	Potent inhibitors of protein farnesyltransferase: Heteroarenes as cysteine replacements Bioorganic & Medicinal Chemistry Letters ·Shen Wang, Stephen A. Fakhoury, Vivek Sharma, Kenneth J. Henry, R. Marynowski, Haichao Zhang, Jerry D. Cohen, Robert R. Warner, Carlos Hernaiz Alonso, Sajeev Cherian, Stephen K. Tahir, Peter Kovar, Joy Bauch, Shi‐Chung Ng, Kennan Marsh, Hing L. Sham, Saul H. Rosenberg	1999	7
13	Design of sustained-release matrix systems for a highly water-soluble compound, ABT-089 International Journal of Pharmaceutics ·Yihong Qiu, Herz Katharina, Kennan Marsh, V. B. Dudkikova, Jay Trivedi, Stephen P. Arnerić, Steven L. Krill	1997	12
14	Structure−Activity Studies on 2-Methyl-3-(2(S)-pyrrolidinylmethoxy)pyridine (ABT-089): An Orally Bioavailable 3-Pyridyl Ether Nicotinic Acetylcholine Receptor Ligand with Cognition-Enhancing Properties Journal of Medicinal Chemistry ·Nan‐Horng Lin, David Gunn, Keith B. Ryther, David S. Garvey, Diana L. Donnelly‐Roberts, Michael Decker, Jorge D. Brioni, Michael Buckley, A. David Rodrigues, Kennan Marsh, David J. Anderson, Jerry J. Buccafusco, Mark Prendergast, James P. Sullivan, Michael Williams, Stephen P. Arnerić, Mark W. Holladay	1997	44
15	ChemInform Abstract: Structure‐Activity Studies on 2‐Methyl‐3‐(2(S)‐pyrrolidinylmethoxy) pyridine (ABT‐089): An Orally Bioavailable 3‐Pyridyl Ether Nicotinic Acetylcholine Receptor Ligand with Cognition‐Enhancing Properties. ChemInform ·Alex B. Bodenstab, David Gunn, Keith B. Ryther, David S. Garvey, Diana L. Donnelly‐Roberts, Michael Decker, Jorge D. Brioni, Michael Buckley, A. David Rodrigues, Kennan Marsh, David J. Anderson, Jerry J. Buccafusco, Mark Prendergast, James P. Sullivan, Michael Williams, Stephen P. Arnerić, Mark W. Holladay	1997	2
16	Stereoselective Metabolism of the 5‐Lipoxygenase Inhibitor A‐78773 Annals of the New York Academy of Sciences ·George W. Carter, Randy L. Bell, Kennan Marsh, Carmine Lanni, Walid M. Awni, Jennifer B. Bouska, Andrew O. Stewart, Karol Bunkowski, Louise M. Dubé, Dee W. Brooks	1994	4
17	New inhibitors of renin that contain novel phosphostatine Leu-Val replacements Journal of Medicinal Chemistry ·Joseph F. Dellaria, Robert G. Maki, Herman H. Stein, Jerome Cohen, David N. Whittern, Kennan Marsh, Daniël J. Hoffman, Jacob J. Plattner, Thomas J. Perun	1990	96

About Kennan Marsh

Kennan Marsh is a scholar working on Pharmacology, Molecular Biology, Pharmaceutical Science, Organic Chemistry and Pharmacology, having authored 17 papers that have together received 1.5k indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (3 papers), Nicotinic Acetylcholine Receptors Study (3 papers), Click Chemistry and Applications (2 papers), Cancer Treatment and Pharmacology (2 papers), Retinoids in leukemia and cellular processes (2 papers), Histone Deacetylase Inhibitors Research (2 papers), Receptor Mechanisms and Signaling (2 papers) and Angiogenesis and VEGF in Cancer (2 papers). The work is most often cited by research in Organic Chemistry (551 citations), Molecular Biology (848 citations), Physiology (53 citations), Endocrinology, Diabetes and Metabolism (183 citations) and Geriatrics and Gerontology (43 citations). Kennan Marsh has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Barbara L. Cool, Robert Dickinson, Ernst U. Frevert, Paul Jung, Ning Cao, William J. Chiou, Bradley A. Zinker, Gang Zhao, Philip R. Kym and Heidi S. Camp. Their work appears in journals such as Journal of Medicinal Chemistry, Bioorganic & Medicinal Chemistry Letters, Journal of Clinical Oncology, Cell Metabolism and Alzheimer s & Dementia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact